Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Interleukin-6 and lipoprotein-associated phospholipase A2 are associated with functional trajectories.

Dhamoon MS, Cheung YK, Moon YP, Wright CB, Sacco RL, Elkind MSV.

PLoS One. 2019 Apr 1;14(4):e0214784. doi: 10.1371/journal.pone.0214784. eCollection 2019.

2.

Association Between Subclinical Brain Infarcts and Functional Decline Trajectories.

Dhamoon MS, Cheung YK, DeRosa JT, Gutierrez J, Moon YP, Sacco RL, Elkind MSV, Wright CB.

J Am Geriatr Soc. 2018 Nov;66(11):2144-2150. doi: 10.1111/jgs.15557. Epub 2018 Sep 25.

PMID:
30251251
3.

Diet Soda and Sugar-Sweetened Soda Consumption in Relation to Incident Diabetes in the Northern Manhattan Study.

Gardener H, Moon YP, Rundek T, Elkind MSV, Sacco RL.

Curr Dev Nutr. 2018 Jan 30;2(5):nzy008. doi: 10.1093/cdn/nzy008. eCollection 2018 May.

4.

Regional Subclinical Cerebrovascular Disease Is Associated with Balance in an Elderly Multi-Ethnic Population.

Willey JZ, Moon YP, Dhamoon MS, Kulick ER, Bagci A, Alperin N, Cheung YK, Wright CB, Sacco RL, Elkind MSV.

Neuroepidemiology. 2018;51(1-2):57-63. doi: 10.1159/000490351. Epub 2018 Jun 28.

5.

Mentored peer review of standardized manuscripts as a teaching tool for residents: a pilot randomized controlled multi-center study.

Wong VSS, Strowd RE 3rd, Aragón-García R, Moon YP, Ford B, Haut SR, Kass JS, London ZN, Mays M, Milligan TA, Price RS, Reynolds PS, Selwa LM, Spencer DC, Elkind MSV.

Res Integr Peer Rev. 2017 Jun 5;2:6. doi: 10.1186/s41073-017-0032-0. eCollection 2017.

6.

Functional Trajectories, Cognition, and Subclinical Cerebrovascular Disease.

Dhamoon MS, Cheung YK, Gutierrez J, Moon YP, Sacco RL, Elkind MSV, Wright CB.

Stroke. 2018 Mar;49(3):549-555. doi: 10.1161/STROKEAHA.117.019595. Epub 2018 Jan 26.

7.

Physical Inactivity Predicts Slow Gait Speed in an Elderly Multi-Ethnic Cohort Study: The Northern Manhattan Study.

Willey JZ, Moon YP, Kulick ER, Cheung YK, Wright CB, Sacco RL, Elkind MSV.

Neuroepidemiology. 2017;49(1-2):24-30. doi: 10.1159/000479695. Epub 2017 Aug 16.

8.

Association Between Serum Tumor Necrosis Factor Receptor 1 and Trajectories of Functional Status: The Northern Manhattan Study.

Dhamoon MS, Cheung YK, Moon YP, Wright CB, Willey JZ, Sacco RL, Elkind MSV.

Am J Epidemiol. 2017 Jul 1;186(1):11-20. doi: 10.1093/aje/kwx035.

9.

Quality of life independently predicts long-term mortality but not vascular events: the Northern Manhattan Study.

Liang JW, Cheung YK, Willey JZ, Moon YP, Sacco RL, Elkind MSV, Dhamoon MS.

Qual Life Res. 2017 Aug;26(8):2219-2228. doi: 10.1007/s11136-017-1567-8. Epub 2017 Mar 29.

10.

C-reactive protein is associated with disability independently of vascular events: the Northern Manhattan Study.

Dhamoon MS, Cheung YK, Moon YP, Wright CB, Willey JZ, Sacco R, Elkind MS.

Age Ageing. 2017 Jan 15;46(1):77-83. doi: 10.1093/ageing/afw179.

11.

Physical inactivity is a strong risk factor for stroke in the oldest old: Findings from a multi-ethnic population (the Northern Manhattan Study).

Willey JZ, Moon YP, Sacco RL, Greenlee H, Diaz KM, Wright CB, Elkind MS, Cheung YK.

Int J Stroke. 2017 Feb;12(2):197-200. doi: 10.1177/1747493016676614. Epub 2016 Oct 26.

12.

Leisure-Time Physical Activity and Cardiovascular Mortality in an Elderly Population in Northern Manhattan: A Prospective Cohort Study.

Cheung YK, Moon YP, Kulick ER, Sacco RL, Elkind MS, Willey JZ.

J Gen Intern Med. 2017 Feb;32(2):168-174. doi: 10.1007/s11606-016-3884-y. Epub 2016 Oct 17.

13.

Procalcitonin and Midregional Proatrial Natriuretic Peptide as Markers of Ischemic Stroke: The Northern Manhattan Study.

Katan M, Moon YP, Paik MC, Mueller B, Huber A, Sacco RL, Elkind MS.

Stroke. 2016 Jul;47(7):1714-9. doi: 10.1161/STROKEAHA.115.011392. Epub 2016 May 19.

14.

Leisure-time physical activity associates with cognitive decline: The Northern Manhattan Study.

Willey JZ, Gardener H, Caunca MR, Moon YP, Dong C, Cheung YK, Sacco RL, Elkind MS, Wright CB.

Neurology. 2016 May 17;86(20):1897-903. doi: 10.1212/WNL.0000000000002582. Epub 2016 Mar 23.

15.

Racial-ethnic disparities in the association between risk factors and diabetes: The Northern Manhattan Study.

Kulick ER, Moon YP, Cheung K, Willey JZ, Sacco RL, Elkind MS.

Prev Med. 2016 Feb;83:31-6. doi: 10.1016/j.ypmed.2015.11.023. Epub 2015 Dec 4.

16.

Electrocardiographic Left Atrial Abnormality and Risk of Stroke: Northern Manhattan Study.

Kamel H, Hunter M, Moon YP, Yaghi S, Cheung K, Di Tullio MR, Okin PM, Sacco RL, Soliman EZ, Elkind MS.

Stroke. 2015 Nov;46(11):3208-12. doi: 10.1161/STROKEAHA.115.009989. Epub 2015 Sep 22.

17.

Leisure-time physical activity and mortality in a multiethnic prospective cohort study: the Northern Manhattan Study.

Willey JZ, Moon YP, Sherzai A, Cheung YK, Sacco RL, Elkind MS.

Ann Epidemiol. 2015 Jul;25(7):475-479.e2. doi: 10.1016/j.annepidem.2015.04.001. Epub 2015 Apr 18.

18.

Left atrial enlargement and stroke recurrence: the Northern Manhattan Stroke Study.

Yaghi S, Moon YP, Mora-McLaughlin C, Willey JZ, Cheung K, Di Tullio MR, Homma S, Kamel H, Sacco RL, Elkind MS.

Stroke. 2015 Jun;46(6):1488-93. doi: 10.1161/STROKEAHA.115.008711. Epub 2015 Apr 23.

19.

The association between a Mediterranean-style diet and kidney function in the Northern Manhattan Study cohort.

Khatri M, Moon YP, Scarmeas N, Gu Y, Gardener H, Cheung K, Wright CB, Sacco RL, Nickolas TL, Elkind MS.

Clin J Am Soc Nephrol. 2014 Nov 7;9(11):1868-75. doi: 10.2215/CJN.01080114. Epub 2014 Oct 30.

20.

Population attributable risks of hypertension and diabetes for cardiovascular disease and stroke in the northern Manhattan study.

Willey JZ, Moon YP, Kahn E, Rodriguez CJ, Rundek T, Cheung K, Sacco RL, Elkind MS.

J Am Heart Assoc. 2014 Sep 16;3(5):e001106. doi: 10.1161/JAHA.114.001106.

21.

Lipid profile components and subclinical cerebrovascular disease in the northern Manhattan study.

Willey JZ, Gardener H, Moon YP, Yoshita M, DeCarli C, Cheung YK, Sacco RL, Elkind MS, Wright CB.

Cerebrovasc Dis. 2014;37(6):423-30. doi: 10.1159/000362920. Epub 2014 Jul 12.

22.

High-sensitivity C-reactive protein and interleukin-6-dominant inflammation and ischemic stroke risk: the northern Manhattan study.

Luna JM, Moon YP, Liu KM, Spitalnik S, Paik MC, Cheung K, Sacco RL, Elkind MS.

Stroke. 2014 Apr;45(4):979-87. doi: 10.1161/STROKEAHA.113.002289. Epub 2014 Mar 13.

23.

Diabetes predicts long-term disability in an elderly urban cohort: the Northern Manhattan Study.

Dhamoon MS, Moon YP, Paik MC, Sacco RL, Elkind MS.

Ann Epidemiol. 2014 May;24(5):362-368.e1. doi: 10.1016/j.annepidem.2013.12.013. Epub 2014 Jan 3.

24.

Lipoprotein-associated phospholipase A2 is associated with atherosclerotic stroke risk: the Northern Manhattan Study.

Katan M, Moon YP, Paik MC, Wolfert RL, Sacco RL, Elkind MS.

PLoS One. 2014 Jan 9;9(1):e83393. doi: 10.1371/journal.pone.0083393. eCollection 2014.

25.

Infectious burden and cognitive function: the Northern Manhattan Study.

Katan M, Moon YP, Paik MC, Sacco RL, Wright CB, Elkind MS.

Neurology. 2013 Mar 26;80(13):1209-15. doi: 10.1212/WNL.0b013e3182896e79.

26.

Interleukin 6 plasma concentration associates with cognitive decline: the northern Manhattan study.

Economos A, Wright CB, Moon YP, Rundek T, Rabbani L, Paik MC, Sacco RL, Elkind MS.

Neuroepidemiology. 2013;40(4):253-9. doi: 10.1159/000343276. Epub 2013 Jan 24.

27.

Trajectory of functional decline before and after ischemic stroke: the Northern Manhattan Study.

Dhamoon MS, Moon YP, Paik MC, Sacco RL, Elkind MS.

Stroke. 2012 Aug;43(8):2180-4. doi: 10.1161/STROKEAHA.112.658922. Epub 2012 May 29.

28.

Coronary death and myocardial infarction among Hispanics in the Northern Manhattan Study: exploring the Hispanic paradox.

Willey JZ, Rodriguez CJ, Moon YP, Paik MC, Di Tullio MR, Homma S, Sacco RL, Elkind MS.

Ann Epidemiol. 2012 May;22(5):303-9. doi: 10.1016/j.annepidem.2012.02.014. Epub 2012 Mar 15.

29.

Duration of diabetes and risk of ischemic stroke: the Northern Manhattan Study.

Banerjee C, Moon YP, Paik MC, Rundek T, Mora-McLaughlin C, Vieira JR, Sacco RL, Elkind MS.

Stroke. 2012 May;43(5):1212-7. doi: 10.1161/STROKEAHA.111.641381. Epub 2012 Mar 1.

30.

The metabolic syndrome and cognitive performance: the Northern Manhattan Study.

Vieira JR, Elkind MS, Moon YP, Rundek T, Boden-Albala B, Paik MC, Sacco RL, Wright CB.

Neuroepidemiology. 2011;37(3-4):153-9. doi: 10.1159/000332208. Epub 2011 Oct 15.

31.

The inclusion of stroke in risk stratification for primary prevention of vascular events: the Northern Manhattan Study.

Dhamoon MS, Moon YP, Paik MC, Sacco RL, Elkind MS.

Stroke. 2011 Oct;42(10):2878-82. doi: 10.1161/STROKEAHA.111.616912. Epub 2011 Aug 18.

32.

Lower prevalence of silent brain infarcts in the physically active: the Northern Manhattan Study.

Willey JZ, Moon YP, Paik MC, Yoshita M, Decarli C, Sacco RL, Elkind MS, Wright CB.

Neurology. 2011 Jun 14;76(24):2112-8. doi: 10.1212/WNL.0b013e31821f4472. Epub 2011 Jun 8.

33.

Race-ethnic differences in the association between lipid profile components and risk of myocardial infarction: The Northern Manhattan Study.

Willey JZ, Rodriguez CJ, Carlino RF, Moon YP, Paik MC, Boden-Albala B, Sacco RL, DiTullio MR, Homma S, Elkind MS.

Am Heart J. 2011 May;161(5):886-92. doi: 10.1016/j.ahj.2011.01.018.

34.

Association of serum soluble receptor for advanced glycation end-products with subclinical cerebrovascular disease: the Northern Manhattan Study (NOMAS).

Hudson BI, Moon YP, Kalea AZ, Khatri M, Marquez C, Schmidt AM, Paik MC, Yoshita M, Sacco RL, DeCarli C, Wright CB, Elkind MS.

Atherosclerosis. 2011 May;216(1):192-8. doi: 10.1016/j.atherosclerosis.2011.01.024. Epub 2011 Jan 21.

35.

Early depressed mood after stroke predicts long-term disability: the Northern Manhattan Stroke Study (NOMASS).

Willey JZ, Disla N, Moon YP, Paik MC, Sacco RL, Boden-Albala B, Elkind MS, Wright CB.

Stroke. 2010 Sep;41(9):1896-900. doi: 10.1161/STROKEAHA.110.583997. Epub 2010 Jul 29.

36.

Quality of life declines after first ischemic stroke. The Northern Manhattan Study.

Dhamoon MS, Moon YP, Paik MC, Boden-Albala B, Rundek T, Sacco RL, Elkind MS.

Neurology. 2010 Jul 27;75(4):328-34. doi: 10.1212/WNL.0b013e3181ea9f03. Epub 2010 Jun 23.

37.

Infectious burden and carotid plaque thickness: the northern Manhattan study.

Elkind MS, Luna JM, Moon YP, Boden-Albala B, Liu KM, Spitalnik S, Rundek T, Sacco RL, Paik MC.

Stroke. 2010 Mar;41(3):e117-22. doi: 10.1161/STROKEAHA.109.571299. Epub 2010 Jan 14.

38.

Physical activity and risk of ischemic stroke in the Northern Manhattan Study.

Willey JZ, Moon YP, Paik MC, Boden-Albala B, Sacco RL, Elkind MS.

Neurology. 2009 Nov 24;73(21):1774-9. doi: 10.1212/WNL.0b013e3181c34b58.

39.

Lipid profile components and risk of ischemic stroke: the Northern Manhattan Study (NOMAS).

Willey JZ, Xu Q, Boden-Albala B, Paik MC, Moon YP, Sacco RL, Elkind MS.

Arch Neurol. 2009 Nov;66(11):1400-6. doi: 10.1001/archneurol.2009.210.

40.

Infectious burden and risk of stroke: the northern Manhattan study.

Elkind MS, Ramakrishnan P, Moon YP, Boden-Albala B, Liu KM, Spitalnik SL, Rundek T, Sacco RL, Paik MC.

Arch Neurol. 2010 Jan;67(1):33-8. doi: 10.1001/archneurol.2009.271. Epub 2009 Nov 9.

41.

High-sensitivity C-reactive protein predicts mortality but not stroke: the Northern Manhattan Study.

Elkind MS, Luna JM, Moon YP, Liu KM, Spitalnik SL, Paik MC, Sacco RL.

Neurology. 2009 Oct 20;73(16):1300-7. doi: 10.1212/WNL.0b013e3181bd10bc.

42.

CKD associates with cognitive decline.

Khatri M, Nickolas T, Moon YP, Paik MC, Rundek T, Elkind MS, Sacco RL, Wright CB.

J Am Soc Nephrol. 2009 Nov;20(11):2427-32. doi: 10.1681/ASN.2008101090. Epub 2009 Sep 3.

43.

High-sensitivity C-reactive protein and lipoprotein-associated phospholipase A2 stability before and after stroke and myocardial infarction.

Elkind MS, Leon V, Moon YP, Paik MC, Sacco RL.

Stroke. 2009 Oct;40(10):3233-7. doi: 10.1161/STROKEAHA.109.552802. Epub 2009 Jul 30.

44.

Long-term functional recovery after first ischemic stroke: the Northern Manhattan Study.

Dhamoon MS, Moon YP, Paik MC, Boden-Albala B, Rundek T, Sacco RL, Elkind MS.

Stroke. 2009 Aug;40(8):2805-11. doi: 10.1161/STROKEAHA.109.549576. Epub 2009 Jun 25.

45.

Non-combustible waste vitrification with plasma torch melter.

Park JK, Moon YP, Park BC, Song MJ, Ko KS, Cho JM.

J Environ Sci Health A Tox Hazard Subst Environ Eng. 2001 May;36(5):861-71.

PMID:
11460337

Supplemental Content

Support Center